Natco Pharma Shares Drop 15 Following Weak Q4 Results Net Profit Falls 34 YoY WHWK Q1 2026 Earnings NarrowerThanExpected Loss as EPS Surpasses Estimates by 12 Xs Content Crackdown Targets Revenue Share Abuse by Major Accounts